[1]王均华 肖蔚林 杨依然 史晓林△.金天格胶囊对股骨粗隆间骨折患者术后骨密度影响的临床研究[J].中国中医骨伤科杂志,2018,26(08):26-29.
　WANG Junhua XIAO Weilin YANG Yiran SHI Xiaolin.Effect and Safety of Jintiange Capsule for Treating Osteoporotic Intertrochanteric Fracture after Operation[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2018,26(08):26-29.
点击复制

金天格胶囊对股骨粗隆间骨折患者术后骨密度影响的临床研究()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第26卷
期数:
2018年08期
页码:
26-29
栏目:
临床研究
出版日期:
2018-08-02

文章信息/Info

Title:
Effect and Safety of Jintiange Capsule for Treating Osteoporotic Intertrochanteric Fracture after Operation
文章编号:
1005-0205(2018)08-0026-04
作者:
王均华1 肖蔚林1 杨依然1 史晓林1; 2△
1浙江中医药大学附属第二医院(杭州,310053) 2浙江中医药大学
Author(s):
WANG Junhua1 XIAO Weilin1 YANG Yiran1 SHI Xiaolin1; 2△
1Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou 310053, China; 2Zhejiang University of Traditional Chinese Medicine, Hangzhou 310005, China.
关键词:
金天格胶囊;  肝肾亏虚;  骨质疏松性股骨粗隆间骨折术后;  骨密度
Keywords:
Keywords: jintiange capsules;  liver and kidney deficiency;  osteoporotic intertrochanteric fracture after operation;  bone mineral density
分类号:
R683.42
文献标志码:
A
摘要:
目的:观察金天格胶囊治疗肝肾亏虚型骨质疏松性股骨粗隆间骨折对患者术后骨密度的影响。方法:选取68例肝肾亏虚型骨质疏松性股骨粗隆间骨折术后的患者,采用随机数字表法将其随机分为观察组和对照组,每组34例,均治疗6个月。观察组口服金天格胶囊,对照组口服钙尔奇D3片,对比两组患者治疗前和治疗6个月后的骨密度,骨代谢指标,3个月和6个月后的VAS评分及两组在治疗后不同时间段的骨痂评分和骨折愈合时间。结果:观察组治疗后骨密度明显升高,差异有统计学意义(P<0.01),且两组治疗后差异有统计学意义(P<0.05)。观察组治疗后血清钙、骨钙素(BGP)、碱性磷酸酶差异有统计学意义(P<0.01); 在治疗3个月后两组VAS评分比较,差异无统计学意义(P>0.05),但6个月后两组差异有统计学意义(P<0.01)。观察组和对照组在治疗不同时间段后,断端骨痂X线评分对比均提示差异有统计学意义(P<0.05); 但骨折愈合时间两组相比较差异无统计学意义(P>0.05)。结论:金天格胶囊用于肝肾亏虚型骨质疏松性股骨粗隆间骨折术后的患者,能有效增加骨密度和缓解疼痛,促进骨痂形成并且用药安全,值得临床推广。
Abstract:
Abstracts Objective:To observe the effectiveness and safety of Jintiange capsule in the treatment of osteoporotic intertrochanteric fracture after operation.Methods: Sixty-eight patients with postoperative osteoporotic intertrochanteric fractures were randomized into observation and control groups using a random number table method.Each group consisted of 34 patients who were treated for 6 months.The observation group was given oral Jintiange capsule and the control group was given oral calcium gel D3 tablets.The BMD, bone metabolism index, VAS scores after 3 months and 6 months were compared between the two groups.The scores of bone spasm and fracture healing time at different time points after treatment were compared between the two groups.Results:Bone mineral density was significantly increased in the observation group before and after treatment(P<0.01), and there was a statistically significant difference between the two groups after treatment(P<0.05).Serum calcium and osteocalcin(BGP)were observed in the observation group before and after treatment in the observation group.There was a significant difference(P<0.01); after 3 months of treatment, there was no statistically significant difference in the VAS score between the observation group and the control group(P>0.05), but after 6 months of treatment, there was a statistically significant difference between the two groups(P<0.01).The X-ray scores of the fractured iliac crest between the observation group and the control group at different time points indicated that the difference was statistically significant(P<0.05); however, the fracture healing time had no significant difference between the two groups(P>0.05).Conclusion: Jintiange capsules are used for the treatment of osteoporotic femoral intertrochanteric fractures after surgery, which can effectively increase the bone density and relieve pain, promote the formation of bone callus and are safe to use.It is worthy of clinical promotion.

参考文献/References:

[1] 柴生颋,谢平金,万雷,等.体重及体质量指数与骨质疏松性骨折发生的关系研究[J].中国骨质疏松杂志,2018,24(2):156-160. [2] 戴海,黄宗贵,徐应龙.股骨近端防旋髓内钉和人工股骨头置换术治疗老年性股骨粗隆间骨折的对比研究[J].广西医学,2015,37(2):247-248. [3] 夏雪,马陈,沈霖,等.古方青娥丸治疗绝经后骨质疏松症的临床疗效观察[J].中国中医骨伤科杂志,2016,24(7):20-22. [4] 原发性骨质疏松症诊疗指南(2017)[J].中国全科医学,2017,20(32):3963-3982. [5] 余作取,王锋,戴寿旺,等.股骨粗隆间骨折股骨近端防旋髓内钉内固定前后四物汤加味与肝素联合预防血栓的应用研究[J].中华中医药学刊,2018,36(2):502-506. [6] 国家中医药管理局.中医病症诊断疗效标准[M].北京:中国医药科技出版社,2012:208. [7] 陈达,彭力平,余阗,等.“六味骨痹汤”治疗膝骨关节炎疗效及安全性的临床研究[J].中国中医骨伤科杂志,2017,25(5):26-29. [8] 陈德强,贾世孔,雪原,等.金天格辅助治疗老年股骨转子周围骨折的疗效分析[J].中国骨质疏松杂志,2015,21(12):1501-1503. [9] 彭宇,李凯.生骨汤促进股骨粗隆骨折愈合的临床疗效研究[J].中医临床研究,2016,8(33):123-124. [10] 李春雯,史晓林.益气温经方防治绝经后骨质疏松性髋部骨折的骨密度及SF-36疗效评价[J].中国现代应用药学,2015,32(5):592-595. [11] 陈艳婷,邓伟民.邓伟民治疗绝经后骨质疏松症经验介绍[J].新中医,2018,50(3):212-214. [12] 陈文勇.骨愈灵Ⅱ号在老年稳定型股骨粗隆间骨折PFNA治疗中的应用[D].福州:福建中医药大学,2013. [13] 国家中医药管理局.22个专业95个病种中医诊疗方案[M].北京:中国中医药出版社,2010:129-130. [14] 何保玉,滕涛,刘宝戈,等.金天格胶囊治疗原发性骨质疏松症的临床疗效观察[J].中国骨质疏松杂志,2015,21(2):168-174. [15] 张军,孙树椿,王和鸣,等.金天格胶囊治疗原发性骨质疏松症660例临床疗效[J].中国骨质疏松杂志,2005,11(4):490-495.

备注/Memo

备注/Memo:
基金项目:浙江省中医药重点研究计划(2012ZZ007) △通信作者 E-mail:591072121@qq.com
更新日期/Last Update: 2018-08-02